Background: The TREatment of ATopic eczema (TREAT) Registry Taskforce is a collaborative international network of registries collecting data of atopic eczema (AE) patients receiving systemic and phototherapy with the common goal to provide long-term real-world data on the effectiveness, safety and cost-effectiveness of therapies. A core dataset, consisting of domains and domain items with corresponding measurement instruments, has been developed to harmonize data collection. Objectives: We aimed to give an overview of the status and characteristics of the eight established TREAT registries, and to perform a mapping exercise to examine the degree of overlap and pooling ability between the national registry datasets. This will allow us to det...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharma-...
Background: A long-term prospective observational safety study is essential to characterize fully th...
International audienceBackground A long-term prospective observational safety study is essential to ...
Background: The TREatment of ATopic eczema (TREAT) Registry Taskforce is a collaborative internation...
Background: Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE...
BACKGROUND:Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE)...
Background Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE)...
Background: Patients with moderate-to-severe atopic eczema (AE) often require photo-or systemic immu...
Background Comparative, real-life and long-term evidence on the effectiveness and safety of photothe...
Background: Comparative, real-life and long-term evidence on the effectiveness and safety of phototh...
BackgroundComparative, real-life and long-term evidence on the effectiveness and safety of photother...
BACKGROUND: Comparative, real-life and long-term evidence on the effectiveness and safety of phototh...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharmac...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharmac...
Importance: A recent expert consensus exercise emphasized the importance of developing a global netw...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharma-...
Background: A long-term prospective observational safety study is essential to characterize fully th...
International audienceBackground A long-term prospective observational safety study is essential to ...
Background: The TREatment of ATopic eczema (TREAT) Registry Taskforce is a collaborative internation...
Background: Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE...
BACKGROUND:Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE)...
Background Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE)...
Background: Patients with moderate-to-severe atopic eczema (AE) often require photo-or systemic immu...
Background Comparative, real-life and long-term evidence on the effectiveness and safety of photothe...
Background: Comparative, real-life and long-term evidence on the effectiveness and safety of phototh...
BackgroundComparative, real-life and long-term evidence on the effectiveness and safety of photother...
BACKGROUND: Comparative, real-life and long-term evidence on the effectiveness and safety of phototh...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharmac...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharmac...
Importance: A recent expert consensus exercise emphasized the importance of developing a global netw...
SwedAD, a Swedish nationwide registry for patients with atopic dermatitis receiving systemic pharma-...
Background: A long-term prospective observational safety study is essential to characterize fully th...
International audienceBackground A long-term prospective observational safety study is essential to ...